共 50 条
- [1] Re: Kaba et al.: The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma (Ophthalmology Glaucoma. 2020;3:181-189) OPHTHALMOLOGY GLAUCOMA, 2021, 4 (01): : E2 - E3
- [2] The Effectiveness and Safety of Micropulse Cyclophotocoagulation in the Treatment of Ocular Hypertension and Glaucoma OPHTHALMOLOGY GLAUCOMA, 2020, 3 (03): : 181 - 189
- [3] Re: Koh et al.: Treatment outcomes using the PAUL glaucoma implant to control intraocular pressure in eyes with refractory glaucoma (Ophthalmology Glaucoma. 2020;3:350-359) REPLY OPHTHALMOLOGY GLAUCOMA, 2021, 4 (01): : E1 - E2
- [4] Re: Kim et al.: Prostaglandin-associated periorbitopathy in children and young adults with glaucoma (Ophthalmology Glaucoma. 2020;3:288-294) OPHTHALMOLOGY GLAUCOMA, 2021, 4 (01): : E4 - E5
- [5] Re: Singh et al.: Trabeculectomy Must Survive! (Ophthalmology Glaucoma. 2021;4:1-2) OPHTHALMOLOGY GLAUCOMA, 2021, 4 (03): : E8 - E9
- [6] Re: Wang et al.: Machine learning models for diagnosing glaucoma from retinal nerve fiber layer thickness maps (Ophthalmology Glaucoma. 2019;2:422-428) REPLY OPHTHALMOLOGY GLAUCOMA, 2020, 3 (03): : E3 - E5
- [7] Re: Schlenker et al.: How mean intraocular pressures are failing patients (Ophthalmology Glaucoma. 2021;4:553-557) OPHTHALMOLOGY GLAUCOMA, 2022, 5 (03): : E14 - E14